GE Healthcare Translates Assays to High Content Analysis, Providing Faster Results

Share Article

In this webinar, which LabRoots will host November 16, participants will learn how to optimize both biology and acquisition in order to quickly make new biological insights using High Content Analysis.

Maggie Vantangoli Policelli, PhD HCA Field Applications Scientist

High Content Analysis (HCA) is a technique utilizing automated microscopy to obtain phenotypic and morphological information. This data rich approach allows you to extract 70+ measurements from every cell in every image. HCA, however, is not just for screening and drug discovery. This powerful technique can be used to optimize experimental conditions, quantify large numbers of cells, increase replicates and is applicable to many routine experiments.

Through this webinar, which is sponsored by GE Healthcare, attendees will better understand how to confidently translate current assay to HCA, as well as determine field of view size, autofocus and other best practices optimize acquisition settings. Attendees will learn how to choose the correct plate for assay to get the best image quality and quantification and determine the correct seeding density and labeling conditions to accurately segment images.

The team at GE Healthcare has arrange for Dr. Maggie Vantangoli Policelli, a HCA Field Applications Scientist, to be the speaker for this event.

Dr. Maggie Vantangoli Policelli received her Bachelor of Science from Bridgewater State College, and doctorate from Brown University, where her research centered on the development of novel three-dimensional platforms for toxicity testing. This research integrated toxicological, morphological and molecular endpoints using high-content imaging-based approaches.

This webinar will be hosted by LabRoots on November 16, 2017, beginning at 11:00 a.m. PST, 2:00 p.m. EST. To read more about this event, learn about the continuing education credits offered, or to register, click here.

GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality, and more affordable healthcare around the world. From medical imaging, software and IT, patient monitoring, and diagnostics to drug discovery, biopharmaceutical manufacturing technologies, and performance improvement solutions, the company helps medical professionals deliver great healthcare to their patients.

LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website